...
首页> 外文期刊>Journal of Neurosurgery. Spine. >The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients.
【24h】

The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients.

机译:颈前路椎间盘切除术以及聚醚醚酮间隔子和重组人骨形态发生蛋白2融合的安全性和有效性:回顾200例患者。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECT: The goal in this study was to demonstrate the safety and efficacy of anterior cervical discectomy and fusion ([ACDF]; single- or multilevel procedure) performed using titanium plates and polyetheretherketone (PEEK) spacers filled with recombinant human bone morphogenetic protein-2 (rhBMP-2) impregnated in a type I collagen sponge to achieve fusion. METHODS: The authors retrospectively reviewed 200 patients who underwent a single- or multilevel ACDF with titanium plate fixation and PEEK spacer filled with a collagen sponge impregnated with low-dose rhBMP-2. Clinical outcomes were assessed using pre- and postoperative Nurick grades and the Odom criteria. Radiographic outcomes were assessed using dynamic radiographs and computed tomography (CT) scans. RESULTS: The follow-up period ranged from 8 to 36 months (mean 16.7 months). A single-level ACDF was performed in 96 patients, 2-level ACDF in 62 patients, 3-level ACDF in 36 patients, and 4-level ACDF in 6 patients. Long-term follow-up was availablefor 193 patients. The Odom outcomes were rated as good to excellent in 165 patients (85%), fair in 24 (12.4%), and poor in 4 (2%). Among patients with myelopathy, Nurick grades improved from a preoperative mean of 1.42 to a postoperative mean of 0.26. All patients (100%) achieved solid radiographic fusion on dynamic radiographs and CT scans. Fourteen patients (7%) in this series experienced clinically significant dysphagia, and 4 (2%) required repeated operation for hematoma or seroma. CONCLUSIONS: An ACDF performed using a PEEK spacer filled with rhBMP-2 leads to good to excellent clinical outcomes and solid fusion, even in multilevel cases and in patients who are smokers. The incidence of symptomatic dysphagia may be decreased with a lower dose of rhBMP-2 that is placed only within the PEEK spacer.
机译:目的:本研究的目的是证明使用填充有重组人骨形态发生蛋白2的钛板和聚醚醚酮(PEEK)垫片进行的颈椎前路椎间盘切除术和融合术([ACDF];单级或多级手术)的安全性和有效性(rhBMP-2)浸入I型胶原海绵中以实现融合。方法:作者回顾性分析了200例行单层或多层ACDF的钛板固定和PEEK垫片填充低剂量rhBMP-2胶原海绵的患者。使用术前和术后Nurick等级和Odom标准评估临床结局。使用动态放射线照片和计算机断层扫描(CT)扫描评估放射线结果。结果:随访时间为8到36个月(平均16.7个月)。单级ACDF治疗96例,2级ACDF治疗62例,3级ACDF治疗36例,4级ACDF治疗6例。 193名患者可以进行长期随访。 Odom结果在165例患者中占优(85%),在24例中占12.4%,在4例中占2%。在患有脊髓病的患者中,Nurick评分从术前平均值1.42提高到术后平均值0.26。所有患者(100%)均在动态X射线照片和CT扫描上获得了可靠的X线影像融合。该系列中有14名患者(7%)经历了临床上明显的吞咽困难,其中4名(2%)因血肿或血清肿而需要重复手术。结论:使用填充有rhBMP-2的PEEK间隔子进行ACDF可以达到良好的临床效果和牢固的融合,即使在多级病例和吸烟患者中也是如此。仅在PEEK间隔物中放置较低剂量的rhBMP-2可以降低症状性吞咽困难的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号